Cipla Limited — Board Meeting, 13-05-2025: Outcome of Board Meeting

Cipla has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue climbed to ₹27,547.62 Cr, up from ₹25,774.09 Cr last year, while net profit surged 27% to ₹5,269.20 Cr, led by pharmaceuticals. Q4 PAT stood at ₹1,214.14 Cr. Standalone profits benefited from an exceptional impairment reversal of ₹294.66 Cr. The company declared a total dividend of ₹16 per share (₹13 final + ₹3 special) celebrating its 90th anniversary. Its generics business was shifted to a wholly owned subsidiary, and operating cash flow remains robust above ₹5,000 Cr.